A simple method to increase the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo

Human Gene Therapy

Volumn 22, Issue 5, 2011, Pages 633-640

  Ma, Wenqin ^a,b   Li, Baozheng ^a,b   Ling, Chen ^a,b,c   Jayandharan, Giridhara R ^a,b,d   Srivastava, Arun ^a,b,c,e,f   Byrne, Barry J ^a,b,c,e,f  

^a Division of Cellular and Molecular Therapy   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Department of Molecular Genetics and Microbiology ^*  (United States)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e UNIVERSITY OF FLORIDA   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; PHOSPHATASE; PROTEIN PHOSPHATASE 5; SINGLE STRANDED ADENO ASSOCIATED VIRUS 2 VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE CASSETTE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VIVO GENE TRANSFER; LIVER CELL; MALE; MOUSE; NONHUMAN; PLASMID; SEROTYPE;

ANIMALS; CELL LINE; CLONING, MOLECULAR; DEPENDOVIRUS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATOCYTES; HUMANS; MALE; MICE; MICE, INBRED C57BL; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PLASMIDS; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS - 2; MURINAE;

EID: 79955376402     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.243     Document Type: Article

References (38)

1. Aitken, M.L., Moss, R.B., Waltz, D.A., et al. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fi-brosis subjects with mild lung disease. Hum. Gene Ther. 12, 1907-1916. (Pubitemid 32947233)
2. Auricchio, A., Hildinger, M., O'Connor, E., et al. (2001). Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71-76. (Pubitemid 32044468)
3. Chen, S.J., Tazelaar, J., and Wilson, J.M. (2001). Selective re-population of normal mouse liver by hepatocytes transduced in vivo with recombinant adeno-associated virus. Hum. Gene Ther. 12, 45-50. (Pubitemid 32044465)
4. Conlon, T.J., and Flotte, T.R. (2004). Recombinant adeno-associated virus vectors for gene therapy. Expert Opin. Biol. Ther. 4, 1093-1101. (Pubitemid 38937551)
5. Ferrari, F.K., Samulski, T., Shenk, T., and Samulski, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234. (Pubitemid 26121941)
6. Fisher, K.J., Gao, G.P., Weitzman, M.D., et al. (1996). Transduc-tion with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532. (Pubitemid 126508820)
7. Flotte, T., Carter, B., Conrad, C., et al. (1996). A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7, 1145-1159. (Pubitemid 26202733)
8. Flotte, T.R., Brantly, M.L., Spencer, L.T., et al. (2004). Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum. Gene Ther. 15, 93-128. (Pubitemid 38147192)
9. Gao, G.P., Alvira, M.R., Wang, L., et al. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U. S. A. 99, 11854-11859. (Pubitemid 34994488)
10. Gao, G.P., Lu, Y., Sun, X., et al. (2006). High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes. J. Virol. 80, 6192-6194. (Pubitemid 43849199)
11. Grieger, J.C., and Samulski, R.J. (2005). Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J. Virol. 79, 9933-9944. (Pubitemid 41022335)
12. Jayandharan, G.R., Zhong, L., Li, B., et al. (2008). Strategies for improving the transduction efficiency of single-stranded ade-no-associated virus vectors in vitro and in vivo. Gene Ther. 15, 1287-1293.
13. Jayandharan, G.R., Zhong, L., Sack, B.K., et al. (2010). Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum. Gene Ther. 21, 271-283.
14. Jiang, H., Lillicrap, D., Patarroyo-White, S., et al. (2006). Multi-year therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 108, 107-115. (Pubitemid 43990618)
15. Kay, M.A., Manno, C.S., Ragni, M.V., et al. (2000). Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet. 24, 257-261. (Pubitemid 30132193)
16. Kube, D.M., and Srivastava, A. (1997). Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions. Nucleic Acids Res. 25, 3375-3376. (Pubitemid 27338702)
17. Mah, C., Qing, K., Khuntirat, B., et al. (1998). Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J. Virol. 72, 9835-9843. (Pubitemid 28520849)
18. Manno, C.S., Chew, A.J., Hutchison, S., et al. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101, 2963-2972. (Pubitemid 36857981)
19. Marshall, E. (2001). Gene therapy. Viral vectors still pack surprises. Science 294, 1640.
20. McCarty, D.M., Monahan, P.E., and Samulski, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254. (Pubitemid 32780813)
21. Muzyczka, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Micro-biol. Immunol. 158, 97-129.
22. Nakai, H., Storm, T.A., and Kay, M.A. (2000). Increasing the size of rAAV-mediated expression cassettes in vivo by intermo-lecular joining of two complementary vectors. Nat. Biotechnol. 18, 527-532. (Pubitemid 30313957)
23. Ponnazhagan, S., Mukherjee, P., Yoder, M.C., et al. (1997). Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 190, 203-210. (Pubitemid 27218304)
24. Qing, K., Hansen, J., Weigel-Kelley, K.A., et al. (2001). Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J. Virol. 75, 8968-8976. (Pubitemid 32851901)
25. Qing, K., Khuntirat, B., Mah, C., et al. (1998). Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72, 1593-1599. (Pubitemid 28116947)
26. Qing, K., Li, W., Zhong, L., et al. (2003). Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein ty-rosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J. Virol. 77, 2741-2746. (Pubitemid 36222799)
27. Qing, K., Wang, X.S., Kube, D.M., et al. (1997). Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. U. S. A. 94, 10879-10884.
28. Sarkar, R., Xiao, W., and Kazazian, H.H., Jr. (2003). A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype. J. Thromb. Hae-most. 1, 220-226.
29. Snyder, R.O., and Francis, J. (2005). Adeno-associated viral vectors for clinical gene transfer studies. Curr. Gene Ther. 5, 311-321. (Pubitemid 40895015)
30. Snyder, R.O., Miao, C.H., Patijn, G.A., et al. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270-276. (Pubitemid 27280211)
31. Song, S., Embury, J., Laipis, P.J., et al. (2001). Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 8, 1299-1306. (Pubitemid 32834298)
32. Wagner, J.A., Nepomuceno, I.B., Messner, A.H., et al. (2002). A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13, 1349-1359. (Pubitemid 35034514)
33. Wang, Z., Ma, H.I., Li, J., et al. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111. (Pubitemid 37536759)
34. Wu, J., Zhao, W., Zhong, L., et al. (2007). Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum. Gene Ther. 18, 171-182. (Pubitemid 46446054)
35. Zhao, W., Wu, J., Zhong, L., and Srivastava, A. (2007). Adeno-associated virus 2-mediated gene transfer: role of a cellular serine/threonine protein phosphatase in augmenting trans-duction efficiency. Gene Ther. 14, 545-550. (Pubitemid 46390927)
36. Zhong, L., Chen, L., Li, Y., et al. (2004a). Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phos-phatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Mol. Ther. 10, 950-957. (Pubitemid 39419920)
37. Zhong, L., Li, W., Yang, Z., et al. (2004b). Improved transduction of primary murine hepatocytes by recombinant adeno-asso-ciated virus 2 vectors in vivo. Gene Ther. 11, 1165-1169. (Pubitemid 39117312)
38. Zhong, L., Li, W., Yang, Z., et al. (2004c). Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine he-matopoietic cells. Hum. Gene Ther. 15, 1207-1218. (Pubitemid 40052433)